Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Probing for and Quantifying Agonist Hydrogen Bonds in α6β2 Nicotinic Acetylcholine Receptors.
Post MR
,
Lester HA
,
Dougherty DA
.
???displayArticle.abstract???
Designing subtype-selective agonists for neuronal nicotinic acetylcholine receptors is a challenging and significant goal aided by intricate knowledge of each subtype's binding patterns. We previously reported that in α6β2 receptors, acetylcholine makes a functional cation-π interaction with Trp149, but nicotine and TC299423 do not, suggesting a distinctive binding site. This work explores hydrogen binding at the backbone carbonyl associated with α6β2 Trp149. Substituting residue i + 1, Thr150, with its α-hydroxy analogue (Tah) attenuates the carbonyl's hydrogen bond accepting ability. At α6(T150Tah)β2, nicotine shows a 24-fold loss of function, TC299423 shows a modest loss, and acetylcholine shows no effect. Nicotine was further analyzed via a double-mutant cycle analysis utilizing N'-methylnicotinium, which indicated a hydrogen bond in α6β2 with a ΔΔG of 2.6 kcal/mol. Thus, even though nicotine does not make the conserved cation-π interaction with Trp149, it still makes a functional hydrogen bond to its associated backbone carbonyl.
Blum,
Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.
2010, Pubmed,
Xenbase
Blum,
Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.
2010,
Pubmed
,
Xenbase
Cashin,
Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase
Colquhoun,
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.
1998,
Pubmed
Daeffler,
Functionally important aromatic-aromatic and sulfur-π interactions in the D2 dopamine receptor.
2012,
Pubmed
,
Xenbase
Deechongkit,
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics.
2004,
Pubmed
Dougherty,
The cation-π interaction.
2013,
Pubmed
Dougherty,
Unnatural amino acids as probes of protein structure and function.
2000,
Pubmed
England,
Backbone mutations in transmembrane domains of a ligand-gated ion channel: implications for the mechanism of gating.
1999,
Pubmed
,
Xenbase
Gotti,
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
2006,
Pubmed
Hassaine,
X-ray structure of the mouse serotonin 5-HT3 receptor.
2014,
Pubmed
Holladay,
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
1997,
Pubmed
Horovitz,
Double-mutant cycles: a powerful tool for analyzing protein structure and function.
1996,
Pubmed
Huang,
Crystal structure of human glycine receptor-α3 bound to antagonist strychnine.
2015,
Pubmed
Le Novère,
The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.
2002,
Pubmed
Lester,
Cys-loop receptors: new twists and turns.
2004,
Pubmed
Marotta,
An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.
2015,
Pubmed
Miles,
A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific way.
2012,
Pubmed
,
Xenbase
Millar,
Assembly and subunit diversity of nicotinic acetylcholine receptors.
2003,
Pubmed
Miller,
Crystal structure of a human GABAA receptor.
2014,
Pubmed
Morales-Perez,
X-ray structure of the human α4β2 nicotinic receptor.
2016,
Pubmed
Post,
Heterologous expression and nonsense suppression provide insights into agonist behavior at α6β2 nicotinic acetylcholine receptors.
2015,
Pubmed
,
Xenbase
Puskar,
Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes.
2011,
Pubmed
,
Xenbase
Quik,
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.
2011,
Pubmed
Quik,
Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.
2006,
Pubmed
Seeman,
The iodomethylation of nicotine. An unusual example of competitive nitrogen alkylation.
1976,
Pubmed
Smart,
Synaptic neurotransmitter-gated receptors.
2012,
Pubmed
Tavares,
Variations in binding among several agonists at two stoichiometries of the neuronal, α4β2 nicotinic receptor.
2012,
Pubmed
Van Arnam,
Functional probes of drug-receptor interactions implicated by structural studies: Cys-loop receptors provide a fertile testing ground.
2014,
Pubmed
Wieskopf,
The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.
2015,
Pubmed
Wonnacott,
Presynaptic nicotinic ACh receptors.
1997,
Pubmed
Xiu,
Nicotine binding to brain receptors requires a strong cation-pi interaction.
2009,
Pubmed
,
Xenbase
Yang,
Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.
2009,
Pubmed
Zoli,
Diversity of native nicotinic receptor subtypes in mammalian brain.
2015,
Pubmed
